Item specifics

UPC:

099967115384

NumberOfItems: 1
Brand:

ONIVA - a Picnic Time brand

Model:

809-00-101-000-0

MPN:

809-00-101-000-0

Manufacturer: Picnic Time
Binding: Lawn & Patio Label: Picnic Time
Publisher: Picnic Time Department: Unisex
ProductGroup: Sports Color:

Purple

PartNumber: 809-00-101-000-0 ISBN:

Not Applicable

EAN:

0689994166376

ONIVA - a Picnic Time brand Portable Folding Sports Chair, Purple

Nationally Ranked Specialties

TRU-SPEC Men's 24-7 Tactical Pant, Brown, 36 x 32-Inch

Building Update

Building Elevated View

University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.

Oboz Bridger Mid B-Dry Waterproof Boots - Men's Size 10.5

News

Merrell Pulse Mid Womens Sz 7 Hiking shoes Boots Waterproof Leather Gore Tex

Minnesota Vikings Replica Helmet on base,NFL Football Poly Helmet,New,550 Size

University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.

Kapok100% Thai Roll Up Mat Fold Out Yoga Mattress Cushion Day Bed

Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.

Edward Bell receives mentor award from Pediatric Academic Societies

Beer Pong Frisbee Game Indoor Outdoor Family Party Tailgating Beach Ideal Fun

Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.

UI study suggests new approach to treating kids with relapsed cancer

TRU-SPEC Men's Lightweight 24-7 Pant, Olive Drab, 32 x 34-Inch

UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.